The assessment of SSBwDM revealed that 32 cases (80%) were receiving oral antidiabetic (OAD) treatment, 3 (7.5%) were receiving only insulin, 9 (22.5%) were receiving both OAD and insulin, and 5 (12.5%) were not receiving any medication related to DM. The gene discussed is INS; the disease is diabetes mellitus.